Your session is about to expire
← Back to Search
Behavioural Intervention
Robotic Pets for Dementia
N/A
Waitlist Available
Led By Joanna D'Elia, MSN, RN, GERO-BC
Research Sponsored by Sarasota Memorial Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged 65 and older
Be older than 65 years old
Must not have
Patients presenting with paranoia, hallucinations, or severe agitation
Patients younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up flyers will be provided to nurse leadership, charge nurses and in unit common areas (e.g., breakroom) 1-2 times a month for them to take the survey. emails will also be sent out with the link to take the survey up to 2 years..
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to provide robotic pets to patients with dementia to enhance their care and reduce the risk of delirium. The robotic pets will be given to patients shortly after admission and will stay with them
Who is the study for?
This trial is for patients with mild-to-moderate dementia admitted to the hospital. They must have a delirium score of 4 or less on the Nu-DESC scale, indicating they are not experiencing severe delirium. The study excludes those scoring above 4, as they may be too disoriented.
What is being tested?
The trial tests if robotic pets can improve care for dementia patients by reducing delirium, medication use, and negative incidents like falls. Patients receive a robotic pet upon admission to keep during their stay and take home.
What are the potential side effects?
There are no direct medical side effects from interacting with a robotic pet; however, there could be psychological impacts such as attachment or frustration if technical issues arise.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I experience paranoia, hallucinations, or severe agitation.
Select...
I am younger than 65 years old.
Select...
I am currently under strict isolation due to a C. diff infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ flyers will be provided to nurse leadership, charge nurses and in unit common areas (e.g., breakroom) 1-2 times a month for them to take the survey. emails will also be sent out with the link to take the survey up to 2 years..
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~flyers will be provided to nurse leadership, charge nurses and in unit common areas (e.g., breakroom) 1-2 times a month for them to take the survey. emails will also be sent out with the link to take the survey up to 2 years..
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
"Code Greys"
Assess how the use of the Joy for All™ companion pet, as compared to standard care, impacts the development or progression of acute delirium in patients with dementia in an acute care setting.
Delirium order set.
+6 moreSecondary study objectives
Determine the registered nurses acceptability of the Joy for All™ companion pet as a form of complementary therapy for patients with dementia in the acute setting.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic PetExperimental Treatment1 Intervention
The intervention group will receive the robotic Joy for All™ pet.
Group II: ControlActive Control1 Intervention
Control group will receive the current standard of care, no robotic pet.
Find a Location
Who is running the clinical trial?
Sarasota Memorial Health Care SystemLead Sponsor
3 Previous Clinical Trials
563 Total Patients Enrolled
Joanna D'Elia, MSN, RN, GERO-BCPrincipal InvestigatorSarasota Memorial Health Care System